Strategic partnership will link DNA data with rich clinical data to identify novel biomarkers for targeted cancer therapies The two companies will utilize AI and multimodal molecular data to unlock ...
New offering makes real-time system visibility accessible to all Zephyr developers, with seamless upgrade paths to advanced profiling and Tracealyzer In embedded development, visibility is everything.
PALO ALTO, Calif. & MCLEAN, Va.--(BUSINESS WIRE)--Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results